NHS Cancer Programme plans rollouts of 1 million tests for use, in 2024
NHS England - 18-Jul-2022Utilising new technologies and tests to detect and diagnose cancer at early stages
Join the club for FREE to access the whole archive and other member benefits.
NHS Oncologist, Academic Clinician Lecturer- Oxford/Birmingham University
Dr Lennard YW Lee is an Academic Clinical Lecturer in Medical Oncology at the University of Oxford and senior clinical research fellow at the University of Birmingham. He is a Medical Oncologist at Oxford University Hospitals NHS Foundation Trust. He works at the NHSE Cancer Programme as clinical advisor for cancer innovations and diagnostics.
Lennard has led major programmes to safeguard, evaluate and protect cancer patients from coronavirus. He was awarded the ACP McElwain Prize for this initiatives. He also is delivering programmes to accelerate the development of multi-cancer early diagnosis blood tests through population-scale studies.
Lennard’s work as a CL at Oxford has on maximised the safety of cancer care during the pandemic through his leadership of the UK Coronavirus Cancer Programme.
Visit website: https://www.england.nhs.uk/author/dr-lennard-lee/
Details last updated 19-Jul-2022
Utilising new technologies and tests to detect and diagnose cancer at early stages
Utilising new technologies and tests to detect and diagnose cancer at early stages